Malaysia Liquid Biopsy Market to 2032
Overview
The Malaysia Liquid Biopsy Market is expected to reach a 31.29 USD Billion by 2032 and is projected to grow at a CAGR of 17.17% from 2025 to 2032.
Revenue, 2024 (USD Billion)
11.51
Forecast, 2032 (USD Billion)
31.29
CAGR, 2024 - 2032
17.17%
Report Coverage
Malaysia
Malaysia Liquid Biopsy Market 2018-2032 USD Billion
Malaysia Liquid Biopsy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 11.51 USD Billion
- Projected Market Size (2032): 31.29 USD Billion
- CAGR (2025-2032): 17.17%
Key Findings of Malaysia Liquid Biopsy Market
- The Malaysia Liquid Biopsy Market was valued at 11.51 USD Billion in 2024.
- The Malaysia Liquid Biopsy Market is likely to grow at a CAGR of 17.17% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Multi-Gene-Parallel Analysis in Technology Segment accounted for the largest share of the market with a revenue of 9.54 USD Billion
- The fastest growing segment Routine Screening in Clinical Application Segment grew Fastest with a CAGR of 19.63% during the forecast period from 2024 to 2032.
Malaysia Liquid Biopsy Market Scope
Malaysia Liquid Biopsy Market Segmentation & Scope
Distribution Channel
- Others
- Third Party Distributor
- Direct Tender
Application
- Non-Cancer Applications
- Cancer Applications
Analytical
- Histology/Imaging
- Proteomic
- Molecular
Sample
- Others
- Saliva & Other Tissue Fluids Sample-Based
- Urine Sample-Based
- Blood Sample-Based
End User
- Others
- Research Centres and Academic Institutes
- Diagnostics Centers
- Reference Laboratories
- Hospitals
Technology
- Single Gene Analysis
- Multi-Gene-Parallel Analysis
Clinical Application
- Others
- Patient Work-Up
- Recurrence Monitoring
- Treatment Monitoring
- Therapy Selection
- Routine Screening
Biomaker
- Others
- Extracellular Vesicles
- Exosomes
- Cell-Free RNA
- Circulating Cell-Free DNA (CFDNA)
- Circulating Tumor Cells (CTCS)
Product
- Services & Software
- Instruments
- Consumables & Accessories
Malaysia Liquid Biopsy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 11.51 USD Billion |
| Market Value in 2032 | 31.29 USD Billion |
| CAGR (2025-2032) | 17.17% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,Application,Analytical,Sample,End User,Technology,Clinical Application,Biomaker,Product |
Regional Insights:
-
Leading Market (2024-2032): Malaysia, leading in terms of revenue 11.51 USD Billion in 2024
- Key Country: Malaysia, leading in terms of revenue with value of 11.51 USD Billion in 2024.
Segments and Scope
-
Malaysia Liquid Biopsy Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Malaysia Liquid Biopsy Market to 2032 with a revenue of 8.51 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in Malaysia Liquid Biopsy Market to 2032 with a Growth rate of 17.74 % in forecast period 2025-2032.
-
Malaysia Liquid Biopsy Market to 2032, By Application
- Cancer Applications is the largest segment in Malaysia Liquid Biopsy Market to 2032 with a revenue of 9.50 USD Billion in the year 2024.
- Cancer Applications is the Fastest growing segment in Malaysia Liquid Biopsy Market to 2032 with a Growth rate of 17.62 % in forecast period 2025-2032.
-
Malaysia Liquid Biopsy Market to 2032, By Analytical
- Molecular is the largest segment in Malaysia Liquid Biopsy Market to 2032 with a revenue of 7.64 USD Billion in the year 2024.
- Proteomic is the Fastest growing segment in Malaysia Liquid Biopsy Market to 2032 with a Growth rate of 17.80 % in forecast period 2025-2032.
-
Malaysia Liquid Biopsy Market to 2032, By Sample
- Blood Sample-Based is the largest segment in Malaysia Liquid Biopsy Market to 2032 with a revenue of 7.47 USD Billion in the year 2024.
- Blood Sample-Based is the Fastest growing segment in Malaysia Liquid Biopsy Market to 2032 with a Growth rate of 18.19 % in forecast period 2025-2032.
-
Malaysia Liquid Biopsy Market to 2032, By End User
- Hospitals is the largest segment in Malaysia Liquid Biopsy Market to 2032 with a revenue of 7.67 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in Malaysia Liquid Biopsy Market to 2032 with a Growth rate of 18.02 % in forecast period 2025-2032.
-
Malaysia Liquid Biopsy Market to 2032, By Technology
- Multi-Gene-Parallel Analysis is the largest segment in Malaysia Liquid Biopsy Market to 2032 with a revenue of 9.54 USD Billion in the year 2024.
- Multi-Gene-Parallel Analysis is the Fastest growing segment in Malaysia Liquid Biopsy Market to 2032 with a Growth rate of 17.67 % in forecast period 2025-2032.
-
Malaysia Liquid Biopsy Market to 2032, By Clinical Application
- Routine Screening is the largest segment in Malaysia Liquid Biopsy Market to 2032 with a revenue of 6.28 USD Billion in the year 2024.
- Routine Screening is the Fastest growing segment in Malaysia Liquid Biopsy Market to 2032 with a Growth rate of 19.63 % in forecast period 2025-2032.
-
Malaysia Liquid Biopsy Market to 2032, By Biomaker
- Circulating Tumor Cells (CTCS) is the largest segment in Malaysia Liquid Biopsy Market to 2032 with a revenue of 6.02 USD Billion in the year 2024.
- Circulating Tumor Cells (CTCS) is the Fastest growing segment in Malaysia Liquid Biopsy Market to 2032 with a Growth rate of 19.13 % in forecast period 2025-2032.
-
Malaysia Liquid Biopsy Market to 2032, By Product
- Consumables & Accessories is the largest segment in Malaysia Liquid Biopsy Market to 2032 with a revenue of 7.30 USD Billion in the year 2024.
- Consumables & Accessories is the Fastest growing segment in Malaysia Liquid Biopsy Market to 2032 with a Growth rate of 17.88 % in forecast period 2025-2032.
Malaysia Liquid Biopsy Market Company Share Analysis
| Company Name |
|
||
| Thermo Fisher Scientific Inc. | |||
| QIAGEN | |||
| Guardant Health | |||
| Exact Sciences Corporation | |||
| F. Hoffmann-La Roche Ltd. | |||
Malaysia Liquid Biopsy Market Geographical Sales Distribution, 2018-2032 USD Billion
Malaysia Liquid Biopsy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Malaysia Liquid Biopsy Market is segmented based on Segmentation Distribution Channel,Application,Analytical,Sample,End User,Technology,Clinical Application,Biomaker,Product.
Malaysia Liquid Biopsy Market was valued at USD 11.51(Revenue in USD Billion) in 2021.
Malaysia Liquid Biopsy Market is projected to grow at a CAGR of 17.17% during the forecast period of 2024 to 2032.
The Multi-Gene-Parallel Analysis segment is expected to dominate the Malaysia Liquid Biopsy Market, holding a largest market share of 9.54 USD Billion in 2024
Malaysia Liquid Biopsy Market Scope
Malaysia Liquid Biopsy Market Segmentation & Scope
Distribution Channel
- Others
- Third Party Distributor
- Direct Tender
Application
- Non-Cancer Applications
- Cancer Applications
Analytical
- Histology/Imaging
- Proteomic
- Molecular
Sample
- Others
- Saliva & Other Tissue Fluids Sample-Based
- Urine Sample-Based
- Blood Sample-Based
End User
- Others
- Research Centres and Academic Institutes
- Diagnostics Centers
- Reference Laboratories
- Hospitals
Technology
- Single Gene Analysis
- Multi-Gene-Parallel Analysis
Clinical Application
- Others
- Patient Work-Up
- Recurrence Monitoring
- Treatment Monitoring
- Therapy Selection
- Routine Screening
Biomaker
- Others
- Extracellular Vesicles
- Exosomes
- Cell-Free RNA
- Circulating Cell-Free DNA (CFDNA)
- Circulating Tumor Cells (CTCS)
Product
- Services & Software
- Instruments
- Consumables & Accessories
Frequently Asked Questions
The Malaysia Liquid Biopsy Market is segmented based on Segmentation Distribution Channel,Application,Analytical,Sample,End User,Technology,Clinical Application,Biomaker,Product.
Malaysia Liquid Biopsy Market was valued at USD 11.51(Revenue in USD Billion) in 2021.
Malaysia Liquid Biopsy Market is projected to grow at a CAGR of 17.17% during the forecast period of 2024 to 2032.
The estimated market value of the Malaysia Liquid Biopsy Market for final year is USD 31.29 (USD Billion).
Malaysia Liquid Biopsy Market Company Profiling
Frequently Asked Questions
The Malaysia Liquid Biopsy Market is segmented based on Segmentation Distribution Channel,Application,Analytical,Sample,End User,Technology,Clinical Application,Biomaker,Product.
Malaysia Liquid Biopsy Market was valued at USD 11.51(Revenue in USD Billion) in 2021.
Malaysia Liquid Biopsy Market is projected to grow at a CAGR of 17.17% during the forecast period of 2024 to 2032.
The estimated market value of the Malaysia Liquid Biopsy Market for final year is USD 31.29 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.